Extrait

- To evaluate the efficacy of treatment with SOF/VEL fixed dose combination (FDC) for 12 weeks in subjects with chronic HCV infection as measured by the proportion of subjects with sustained viral response 12 weeks after cessation of treatment (SVR12) - To evaluate the safety and tolerability of treatment with SOF/VEL for 12 weeks

Critère d'inclusion

• Chronic hepatitis C virus infection

Liens

• euctr